Table 2.
Outpatient medication history for enthesitis-related arthritis (ERA) and other subtypes of juvenile idiopathic arthritis (JIA)
| N (%) | ERA | Persistent Oligoarthritis | Extended Oligoarthritis | RF(+) Polyarthritis |
RF(−) Polyarthritis |
Systemic | Overall |
|---|---|---|---|---|---|---|---|
| n = 73 | n = 33 | n = 22 | n = 9 | n = 19 | n = 25 | n = 181 | |
| NSAIDs | 70 (96) | 33 (100) | 22 (100) | 9 (100) | 19 (100) | 24 (96) | 177 (98) |
| Oral glucocorticoids | 39 (53) | 20 (61) | 18 (82) | 7 (78) | 16 (84) | 18 (72) | 118 (65) |
| Intra-articular glucocorticoid injection | 4 (5) | 1 (3) | 1 (5) | 1 (11) | 0 (0) | 0 (0) | 7 (4) |
| Methotrexate | 54 (74) | 20 (61) | 17 (77) | 6 (67) | 16 (84) | 17 (68) | 130 (72) |
| Sulfasalazine | 45 (62) | 11 (33) | 15 (68) | 4 (44) | 10 (53) | 7 (28) | 92 (51) |
| Azathioprine | 24 (33) | 18 (55) | 16 (73) | 4 (44) | 10 (53) | 16 (64) | 88 (49) |
| Colchicine | 2 (3) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (4) | 3 (2) |
| Cyclosporine | 1 (1) | 2 (6) | 2 (9) | 1 (11) | 1 (5) | 3 (12) | 10 (6) |
| Plaquenil | 12 (16) | 7 (21) | 6 (27) | 6 (67) | 3 (16) | 3 (12) | 37 (20) |
| TNF-α inhibitor | 57 (78) | 19 (58) | 18 (82) | 5 (56) | 17 (89) | 17 (68) | 133 (73) |